Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
FDA Office of Orphan Products Development
Baylor Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins